DCF — ADVENTIST HEALTH REEDLEY
Enterprise Value: $-2.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.1M
Enterprise Value
$-5.6M
PV of Cash Flows
$3.4M
PV of Terminal Value
$5.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $192.7M | $4.4M | 2.0% | $-3.7M | $-3.4M |
| Year 2 | $198.4M | $6.6M | 3.0% | $-2.2M | $-1.8M |
| Year 3 | $204.4M | $8.8M | 4.0% | $-0.8M | $-0.6M |
| Year 4 | $210.5M | $10.1M | 5.0% | $-0.0M | $-0.0M |
| Year 5 | $216.8M | $11.0M | 5.0% | $0.4M | $0.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$187.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.018081970963730872
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5